Which I personally think is far better, because typically (not always of course) academics will share and collaborate, instead of being in walled gardens.
That's because big-pharma companies love to focus on treatments, not on prevention and they also like to focus on controlling the disease instead of curring it.
Like in the case of allergic asthma, why treat a patient once when you can take money from him monthly?
Contraception and sexually transmitted diseases - will the religious right / moral majority voters turn against a representative who supports medical research for these?
What about diseases associated with lifestyle - smoking, alcohol, obesity. Will a parent group ask why X million is going to emphysema research when it could have gone to childhood cancer research instead? What about the anti-vaccine groups? Vegan/Vegetarian groups? Whatever other special interest group or political viewpoint?
I really don't want to see Bill O'Reilly or Rosie O'Donnell on tv expressing their outrage at why funding is going to curing the wrong diseases/disorders.
There's something very wrong there...
I'm in 2 minds about the whole medicine patent thing. One the one hand, as you say, new medicines would not be developed but on the other hand the patents drive the prices so high that people in 3rd world countries cannot afford them. It also means medicines for 3rd world diseases are not worthwhile for the large pharmas. There really needs to be a better balance, maybe spending 5-10% of their R&D on medicines they know will never see it's return on investment but will save many more lives than their high profit products.
The additional profits that come from lobbying after year 20 to keep out generics don't get reinvested into more research, they get reinvested into more lobbying.
I suspect a lot of the talk about counterfeits and generics misses the third category, generics that are contraband in the USA because they are still under patent protection.
Not that I'm a fan of intellectual property, but I do recognize that there are a few areas where the upfront investment to produce the product is so massive, and copying the final product so easy, that it might make sense to guarantee the profits for a period of time.
Does the pro-generic side have any data or counterpoint to that?